SIDETRADE (ALBFR.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:ALBFR • FR0010202606

142 EUR
+7 (+5.19%)
Last: Feb 5, 2026, 07:00 PM
Fundamental Rating

6

Overall ALBFR gets a fundamental rating of 6 out of 10. We evaluated ALBFR against 115 industry peers in the Software industry. ALBFR has an excellent profitability rating, but there are some minor concerns on its financial health. ALBFR shows excellent growth, but is valued quite expensive already. With these ratings, ALBFR could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year ALBFR was profitable.
  • ALBFR had a positive operating cash flow in the past year.
  • Each year in the past 5 years ALBFR has been profitable.
  • ALBFR had a positive operating cash flow in each of the past 5 years.
ALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFALBFR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

1.2 Ratios

  • With a decent Return On Assets value of 9.46%, ALBFR is doing good in the industry, outperforming 69.57% of the companies in the same industry.
  • ALBFR's Return On Equity of 19.66% is fine compared to the rest of the industry. ALBFR outperforms 76.52% of its industry peers.
  • ALBFR has a better Return On Invested Capital (9.28%) than 69.57% of its industry peers.
  • ALBFR had an Average Return On Invested Capital over the past 3 years of 8.57%. This is below the industry average of 13.06%.
  • The 3 year average ROIC (8.57%) for ALBFR is below the current ROIC(9.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.46%
ROE 19.66%
ROIC 9.28%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ALBFR.PA Yearly ROA, ROE, ROICALBFR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • ALBFR has a Profit Margin of 14.17%. This is in the better half of the industry: ALBFR outperforms 62.61% of its industry peers.
  • In the last couple of years the Profit Margin of ALBFR has grown nicely.
  • ALBFR's Operating Margin of 10.85% is fine compared to the rest of the industry. ALBFR outperforms 62.61% of its industry peers.
  • ALBFR's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ALBFR (75.88%) is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of ALBFR has grown nicely.
Industry RankSector Rank
OM 10.85%
PM (TTM) 14.17%
GM 75.88%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
ALBFR.PA Yearly Profit, Operating, Gross MarginsALBFR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • ALBFR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for ALBFR has been increased compared to 1 year ago.
  • The number of shares outstanding for ALBFR has been increased compared to 5 years ago.
  • ALBFR has a better debt/assets ratio than last year.
ALBFR.PA Yearly Shares OutstandingALBFR.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
ALBFR.PA Yearly Total Debt VS Total AssetsALBFR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • ALBFR has an Altman-Z score of 4.45. This indicates that ALBFR is financially healthy and has little risk of bankruptcy at the moment.
  • ALBFR has a Altman-Z score of 4.45. This is in the better half of the industry: ALBFR outperforms 66.09% of its industry peers.
  • ALBFR has a debt to FCF ratio of 1.10. This is a very positive value and a sign of high solvency as it would only need 1.10 years to pay back of all of its debts.
  • ALBFR's Debt to FCF ratio of 1.10 is fine compared to the rest of the industry. ALBFR outperforms 73.91% of its industry peers.
  • ALBFR has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • ALBFR has a Debt to Equity ratio of 0.16. This is in the better half of the industry: ALBFR outperforms 62.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.1
Altman-Z 4.45
ROIC/WACC1.02
WACC9.09%
ALBFR.PA Yearly LT Debt VS Equity VS FCFALBFR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • ALBFR has a Current Ratio of 1.47. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.47, ALBFR is in line with its industry, outperforming 51.30% of the companies in the same industry.
  • ALBFR has a Quick Ratio of 1.47. This is a normal value and indicates that ALBFR is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ALBFR (1.47) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.47
ALBFR.PA Yearly Current Assets VS Current LiabilitesALBFR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 17.87% over the past year.
  • Measured over the past years, ALBFR shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.85% on average per year.
  • ALBFR shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.74%.
  • Measured over the past years, ALBFR shows a quite strong growth in Revenue. The Revenue has been growing by 16.43% on average per year.
EPS 1Y (TTM)17.87%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%13.63%
Revenue 1Y (TTM)24.74%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%18.08%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.42% on average over the next years. This is quite good.
  • Based on estimates for the next years, ALBFR will show a quite strong growth in Revenue. The Revenue will grow by 15.55% on average per year.
EPS Next Y12.28%
EPS Next 2Y9.96%
EPS Next 3Y14.42%
EPS Next 5YN/A
Revenue Next Year12.77%
Revenue Next 2Y16.99%
Revenue Next 3Y15.55%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ALBFR.PA Yearly Revenue VS EstimatesALBFR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
ALBFR.PA Yearly EPS VS EstimatesALBFR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 25.59, the valuation of ALBFR can be described as expensive.
  • 70.43% of the companies in the same industry are more expensive than ALBFR, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, ALBFR is valued at the same level.
  • Based on the Price/Forward Earnings ratio of 21.88, the valuation of ALBFR can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, ALBFR is valued a bit cheaper than the industry average as 70.43% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 27.20. ALBFR is around the same levels.
Industry RankSector Rank
PE 25.59
Fwd PE 21.88
ALBFR.PA Price Earnings VS Forward Price EarningsALBFR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALBFR.
  • ALBFR's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 34.61
EV/EBITDA 23.68
ALBFR.PA Per share dataALBFR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of ALBFR may justify a higher PE ratio.
  • A more expensive valuation may be justified as ALBFR's earnings are expected to grow with 14.42% in the coming years.
PEG (NY)2.08
PEG (5Y)0.92
EPS Next 2Y9.96%
EPS Next 3Y14.42%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALBFR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SIDETRADE

EPA:ALBFR (2/5/2026, 7:00:00 PM)

142

+7 (+5.19%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-20
Earnings (Next)N/A
Inst Owners18.82%
Inst Owner ChangeN/A
Ins Owners35.29%
Ins Owner ChangeN/A
Market Cap213.00M
Revenue(TTM)59.46M
Net Income(TTM)8.43M
Analysts84
Price Target290.7 (104.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.9%
Valuation
Industry RankSector Rank
PE 25.59
Fwd PE 21.88
P/S 3.58
P/FCF 34.61
P/OCF 30.1
P/B 4.97
P/tB 17.85
EV/EBITDA 23.68
EPS(TTM)5.55
EY3.91%
EPS(NY)6.49
Fwd EY4.57%
FCF(TTM)4.1
FCFY2.89%
OCF(TTM)4.72
OCFY3.32%
SpS39.64
BVpS28.58
TBVpS7.96
PEG (NY)2.08
PEG (5Y)0.92
Graham Number59.74
Profitability
Industry RankSector Rank
ROA 9.46%
ROE 19.66%
ROCE 12.63%
ROIC 9.28%
ROICexc 19.81%
ROICexgc N/A
OM 10.85%
PM (TTM) 14.17%
GM 75.88%
FCFM 10.35%
ROA(3y)8.09%
ROA(5y)8.31%
ROE(3y)16.87%
ROE(5y)17.25%
ROIC(3y)8.57%
ROIC(5y)9.37%
ROICexc(3y)18.44%
ROICexc(5y)20.75%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.66%
ROCE(5y)12.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.75%
ROICexc growth 5Y5.4%
OM growth 3Y-11.7%
OM growth 5Y3.49%
PM growth 3Y-0.3%
PM growth 5Y10.94%
GM growth 3Y2.02%
GM growth 5Y2.88%
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.1
Debt/EBITDA 0.88
Cap/Depr 74.39%
Cap/Sales 1.55%
Interest Coverage 250
Cash Conversion 91.99%
Profit Quality 73.03%
Current Ratio 1.47
Quick Ratio 1.47
Altman-Z 4.45
F-Score6
WACC9.09%
ROIC/WACC1.02
Cap/Depr(3y)191.5%
Cap/Depr(5y)202.1%
Cap/Sales(3y)4.08%
Cap/Sales(5y)4.13%
Profit Quality(3y)97.77%
Profit Quality(5y)121.95%
High Growth Momentum
Growth
EPS 1Y (TTM)17.87%
EPS 3Y16.56%
EPS 5Y27.85%
EPS Q2Q%13.63%
EPS Next Y12.28%
EPS Next 2Y9.96%
EPS Next 3Y14.42%
EPS Next 5YN/A
Revenue 1Y (TTM)24.74%
Revenue growth 3Y19.06%
Revenue growth 5Y16.43%
Sales Q2Q%18.08%
Revenue Next Year12.77%
Revenue Next 2Y16.99%
Revenue Next 3Y15.55%
Revenue Next 5YN/A
EBIT growth 1Y16.13%
EBIT growth 3Y5.13%
EBIT growth 5Y20.49%
EBIT Next Year10.63%
EBIT Next 3Y13.67%
EBIT Next 5YN/A
FCF growth 1Y158.61%
FCF growth 3Y12.94%
FCF growth 5Y37.14%
OCF growth 1Y100%
OCF growth 3Y9.02%
OCF growth 5Y29.8%

SIDETRADE / ALBFR.PA FAQ

What is the ChartMill fundamental rating of SIDETRADE (ALBFR.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALBFR.PA.


What is the valuation status of SIDETRADE (ALBFR.PA) stock?

ChartMill assigns a valuation rating of 3 / 10 to SIDETRADE (ALBFR.PA). This can be considered as Overvalued.


How profitable is SIDETRADE (ALBFR.PA) stock?

SIDETRADE (ALBFR.PA) has a profitability rating of 7 / 10.


What is the valuation of SIDETRADE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SIDETRADE (ALBFR.PA) is 25.59 and the Price/Book (PB) ratio is 4.97.


What is the expected EPS growth for SIDETRADE (ALBFR.PA) stock?

The Earnings per Share (EPS) of SIDETRADE (ALBFR.PA) is expected to grow by 12.28% in the next year.